plainpicture/Nordic Life/Terje Rakke As 2025 draws to a close, it is traditional to look back at the year that was and forward to what may come next. Many of us...

Not so futuristic: Saruman with a palantir in The Lord of the RingsLANDMARK MEDIA/Alamy We are approaching the Gregorian New Year, and it’s a great time to ponder what’s coming...

Feedback is New Scientist’s popular sideways look at the latest science and technology news. You can submit items you believe may amuse readers to Feedback by emailing [email protected] A gift...

Bill BrysonDavid Levene/eyevine Rowan Hooper: Bill, when I mentioned in the office that you were coming in, people reacted like I’d said Ryan Gosling or David Beckham was visiting.Bill Bryson:...

We tend to imagine the holiday season as universally joyful and social, full of family gatherings, sparkling lights and shared traditions. But people’s experiences at this time of year are...

(MedPage Today) -- Restricting access to vaccines and discouraging the development of new vaccines are grave public policy and public health mistakes. This will eventually have a catastrophic impact on...

A twice-yearly injectable HIV prevention drug has been approved in the UK, offering a long-acting alternative to daily oral PrEP for those at risk. Medscape News UK Source link :...

(MedPage Today) -- Early initiation of tofersen (Qalsody) was associated with a numerically slower decline in people with SOD1 amyotrophic lateral sclerosis (ALS) compared with delayed treatment, according to data...

(MedPage Today) -- At the recent American Society of Hematology annual meeting, phase I data highlighted a next-generation, CD19-targeted, interleukin-18-secreting "armored" CAR T-cell therapy that is designed to enhance persistence...

(MedPage Today) -- The FDA has expanded the indication of ferric maltol (Accrufer) capsules for the treatment of iron deficiency to include adolescents. The approval makes the drug the first...

Blatten in Switzerland was buried by a landslide in May 2025ALEXANDRE AGRUSTI/AFP via Getty Images In May, the village of Blatten in the Swiss Alps was destroyed when a huge...

(MedPage Today) -- At the San Antonio Breast Cancer Symposium, investigators reported findings from a retrospective study exploring whether routine blood-based immune markers could help predict response to neoadjuvant chemoimmunotherapy...

(MedPage Today) -- Exposure to nonbenzodiazepine sedative hypnotics, known as Z-drugs, in the first trimester of pregnancy was not associated with an increased risk of congenital malformations, a population-based cohort...

Latine adults with hidradenitis suppurativa report unmet wound care and pain needs, perceived discrimination, and challenges with interpreter-mediated communication during dermatology visits. Medscape Medical News Source link : https://www.medscape.com/viewarticle/study-highlights-issues-care-latine-patients-hidradenitis-2025a100103a?src=rss Author...

FOTOGRAFIA INC./Getty Images Cut your sugar, get some exercise, stop smoking, eat your vegetables, take supplements, don’t stress, sleep well. Every day, we are bombarded with information about how to...

(MedPage Today) -- Medicaid programs made more than $200 million in improper payments to healthcare providers between 2021 and 2022 for people who had already died, according to a new...

(MedPage Today) -- Pathophysiologic biomarkers for chronic spontaneous urticaria (CSU) are emerging, which can help better target therapies for the potentially debilitating condition. Heterogeneity in CSU -- characterized by spontaneous...

(MedPage Today) -- The FDA approved a pill version of the GLP-1 receptor agonist semaglutide (Wegovy), making it the first oral GLP-1 agent indicated for weight loss, Novo Nordisk announced...

(MedPage Today) -- Note that some links may require registration or subscription. Amid a heightened volume of health scams, this quiz may help determine your risk of falling for one....

The supernova remnant SNR 0509-67.5 as seen by the European Southern Observatory’s Very Large TelescopeESO/P. Das et al. Background stars (Hubble): K. Noll et al. This two-toned sphere is evidence...